FindTrial
Sign In

Clinical pathological features and prognosis analysis of medullary breast carcinoma

Clinical pathological features and prognosis analysis of medullary breast carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066639
Enrollment
Unknown
Registered
2022-12-12
Start date
2022-12-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medullary carcinoma of the breast

Interventions

Case series:N/A

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) SEER database data Inclusion criteria: 2004-2015, female, ageless, diagnosed as: medullary breast carcinoma, unilateral carcinoma, primary cancer; breast cancer is the only cancer; staging: AJCC 6th edition is stage I-III. (2) Multi-center data Inclusion criteria: Female, age-free, diagnosed as: medullary breast carcinoma, unilateral carcinoma, primary cancer; breast cancer is the only cancer; staging: AJCC 6th edition is stage I-III; undergoing surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria: No follow-up information

Design outcomes

Primary

MeasureTime frame
Overall surviva;BCSS;—

Countries

China

Contacts

Public ContactHou Ling-mi

Affiliated Hospital of North Sichuan Medical College

houlingmi@163.com13890798808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026